Guru Ownership Trend
Guru Analysis for Agios Pharmaceuticals, Inc. (AGIO)
Agios Pharmaceuticals, Inc. (AGIO), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $3.9 M.
Top institutional holders include Paul Tudor Jones and Cliff Asness.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $9.35 M net outflow during the quarter.
Recent activity highlights Cliff Asness who increased their stake by 30.4%. Conversely, Paul Tudor Jones reduced exposure by 5.2%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Agios Pharmaceuticals, Inc. (AGIO)
Major holders include Paul Tudor Jones ($1.97 M), Cliff Asness ($1.23 M). According to the latest reported data, 2 tracked investment managers collectively hold approximately 94,561 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $9.35 M, with 1 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 2 fully exited AGIO. The total reported sell value was $9.64 M.
Yes, 0 managers opened new positions in AGIO, and 1 increased their existing holdings. The total reported buy value was $287,013.88.